TrialBlood advances2024

Isoquercetin for thromboinflammation in sickle cell disease: a randomized double-blind placebo-controlled trial.

Maria A Lizarralde-Iragorri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.